RankingsPricing
  1. JP-listed companies
  2. PhoenixBio Co.,Ltd.
  3. Financials
  4. Revenue

PhoenixBio Co.,Ltd.JP:6190

Market cap
¥2B
P/E ratio
18x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndRevenue (Million JPY)YoY (%)
Mar 31, 20251,541-10.14%
Mar 31, 20241,715-19.24%
Mar 31, 20232,124+60.33%
Mar 31, 20221,325+30.71%
Mar 31, 20211,014-22.68%
Mar 31, 20201,311+6.72%
Mar 31, 20191,228+36.13%
Mar 31, 2018902-26.57%
Mar 31, 20171,229+0.97%
Mar 31, 20161,217+38.13%
Mar 31, 2015881-23.56%
Mar 31, 20141,153+17.56%
Mar 31, 2013980+23.50%
Mar 31, 2012794

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)